Serina Therapeutics, Inc.
SER
Revenue
51.00k
▲46.00k▲920.00%
3 Months ChangeAssets
10.71M
▼-148.00k▼-1.36%
3 Months ChangeLiabilities
27.10M
▲11.94M▲78.71%
3 Months ChangeFree Cash Flow
-1.59M
▲477.00k▲23.07%
48 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-02
Form 8-K
ID: 0001493152-24-039111
2024-09-12
Form 8-K
ID: 0001493152-24-036080
2024-09-05
Form 8-K
ID: 0001493152-24-035028
2024-08-16
Form 8-K
ID: 0001493152-24-032700
2024-08-09
Form 8-K
ID: 0001493152-24-030996
2024-08-09
Form 10-Q
ID: 0001493152-24-030988
2024-07-29
Form 8-K
ID: 0001493152-24-029379
2024-07-18
Form 8-K
ID: 0001493152-24-028363
2024-07-12
Form 8-K
ID: 0001493152-24-027113
2024-06-10
Form 8-K
ID: 0001493152-24-023333